[
  {
    "ts": "2025-08-21T15:58:55+00:00",
    "headline": "J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub",
    "summary": "The deal is part of a wider $55bn investment strategy by J&J to bolster US manufacturing amid pressure from Trump.",
    "url": "https://www.pharmaceutical-technology.com/news/jj-signs-2bn-incumbency-deal-at-cdmo-fujifilms-new-hub/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "7601a6f6-aa58-38ed-9501-be0ef605c955",
      "content": {
        "id": "7601a6f6-aa58-38ed-9501-be0ef605c955",
        "contentType": "STORY",
        "title": "J&J signs $2bn incumbency deal at CDMO Fujifilm’s new hub",
        "description": "",
        "summary": "The deal is part of a wider $55bn investment strategy by J&J to bolster US manufacturing amid pressure from Trump.",
        "pubDate": "2025-08-21T15:58:55Z",
        "displayTime": "2025-08-21T15:58:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/4f72734dee56a7ab9ce1af0e0f4cb0e7",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qW8VHGDCr5vBJZhd1MP6KA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/4f72734dee56a7ab9ce1af0e0f4cb0e7.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M81p2UvLb06kR8kcoGSI0Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/4f72734dee56a7ab9ce1af0e0f4cb0e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/jj-signs-2bn-incumbency-deal-at-cdmo-fujifilms-new-hub/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-signs-2bn-incumbency-155855776.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-21T13:51:00+00:00",
    "headline": "FDA Extends Review Period of REGN's Submission for Eylea HD",
    "summary": "The FDA extends action dates for Regeneron's Eylea HD filings following inspection findings at Catalent Indiana. Nonetheless, Eylea HD remains available through vial administration.",
    "url": "https://finance.yahoo.com/news/fda-extends-review-period-regns-135100541.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "383e063a-bf2a-3dc8-878a-7c7071e9abff",
      "content": {
        "id": "383e063a-bf2a-3dc8-878a-7c7071e9abff",
        "contentType": "STORY",
        "title": "FDA Extends Review Period of REGN's Submission for Eylea HD",
        "description": "",
        "summary": "The FDA extends action dates for Regeneron's Eylea HD filings following inspection findings at Catalent Indiana. Nonetheless, Eylea HD remains available through vial administration.",
        "pubDate": "2025-08-21T13:51:00Z",
        "displayTime": "2025-08-21T13:51:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nURi29Wh6a5rz6SvQvvCDw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gUIojpJE4OxxDca8KkXZsA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1566882a22938942efee3e7508e93e96.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-extends-review-period-regns-135100541.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-extends-review-period-regns-135100541.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-21T11:24:27+00:00",
    "headline": "Novo’s facility issues delay FDA decisions on Regeneron’s Eylea HD",
    "summary": "The FDA has confirmed a pushback to target action dates for Eylea HD, a delay expected by Regeneron.",
    "url": "https://www.pharmaceutical-technology.com/news/novos-facility-issues-delay-fda-decisions-on-regenerons-eylea-hd/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "685139cf-e177-3241-8faa-8a4580a355ec",
      "content": {
        "id": "685139cf-e177-3241-8faa-8a4580a355ec",
        "contentType": "STORY",
        "title": "Novo’s facility issues delay FDA decisions on Regeneron’s Eylea HD",
        "description": "",
        "summary": "The FDA has confirmed a pushback to target action dates for Eylea HD, a delay expected by Regeneron.",
        "pubDate": "2025-08-21T11:24:27Z",
        "displayTime": "2025-08-21T11:24:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/8af902ec79aebc51489303bc896bd117",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aUlH5ayNyWIQ6yMQPuzz4w--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/8af902ec79aebc51489303bc896bd117.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D5ATFVyBMxZYNVKlZzWX.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/8af902ec79aebc51489303bc896bd117.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/novos-facility-issues-delay-fda-decisions-on-regenerons-eylea-hd/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-facility-issues-delay-fda-112427813.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]